![]() |
Volumn , Issue , 2009, Pages 593-601
|
Transplantation in adult ALL.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
TUMOR PROTEIN;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ADULT;
AGE;
ALLOTRANSPLANTATION;
CHILD;
DISEASE MANAGEMENT;
GENETICS;
GRAFT VERSUS LEUKEMIA EFFECT;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
METHODOLOGY;
MIDDLE AGED;
MINIMAL RESIDUAL DISEASE;
MULTICENTER STUDY;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
PATIENT SELECTION;
PHILADELPHIA 1 CHROMOSOME;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REMISSION;
REVIEW;
RISK;
STATISTICS;
SURVIVAL;
TREATMENT OUTCOME;
ADULT;
AGE FACTORS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHILD;
COMBINED MODALITY THERAPY;
DISEASE MANAGEMENT;
GRAFT VS LEUKEMIA EFFECT;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
MIDDLE AGED;
MULTICENTER STUDIES AS TOPIC;
NEOPLASM PROTEINS;
NEOPLASM, RESIDUAL;
PATIENT SELECTION;
PHILADELPHIA CHROMOSOME;
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
REMISSION INDUCTION;
RISK;
SURVIVAL ANALYSIS;
TRANSPLANTATION CONDITIONING;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT OUTCOME;
|
EID: 77949446258
PISSN: None
EISSN: 15204383
Source Type: Journal
DOI: 10.1182/asheducation-2009.1.593 Document Type: Review |
Times cited : (19)
|
References (44)
|